RxDoctor Payments Data

Louella Pritchette, DO

Family Medicine · Ormond Beach, FLNPI 1104161017

Payments from drug & device makers

$22,960in general payments, 2019–2025

Across 84 payments — averaging $273.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$22K
  • GSK$157
  • Amarin Pharma, Inc.$139
  • Indivior Inc.$101
  • AstraZeneca$90
  • Teva Pharmaceuticals USA, Inc.$86
  • plus $172 from 8 others

What the payments were for

  • Consulting fees$22,21497%
  • Food & beverage$7453%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,960 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$4,379
Medicare patients
20
Services billed
88

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin32$44,473
OzempicSemaglutide21$37,671
MounjaroTirzepatide22$26,738
TrulicityDulaglutide22$24,337
EliquisApixaban28$22,276
LinzessLinaclotide13$16,357
FarxigaDapagliflozin Propanediol11$13,045
Janumet XrSitagliptin Phos/Metformin Hcl12$6,247
LantusInsulin Glargine,hum.Rec.Anlog13$3,185
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$2,595
Albuterol Sulfate HfaAlbuterol Sulfate63$2,449
Levothyroxine Sodium197$2,042
Pregabalin42$1,572
Rosuvastatin Calcium220$1,492
Diclofenac Sodium24$1,398

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$23$51,07544 claims
Boehringer IngelheimJardiance$17$44,47332 claims
Novo NordiskOzempic$17$37,67121 claims
AstraZenecaFarxiga$90$13,04511 claims
MerckJanumet Xr$25$6,24712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Ormond Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →